Status:

RECRUITING

Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Spina Bifida

Eligibility:

All Genders

8-18 years

Phase:

NA

Brief Summary

The purpose of this research study is to determine the effectiveness of a treatment called "transcutaneous tibial nerve stimulation" or "TTNS" in the treatment of urinary leakage for patients with spi...

Detailed Description

This study is designed to determine the outcomes of spina bifida patients with neurogenic bladder who receive Transcutaneous Tibial Nerve Stimulation (TTNS) treatment. To identify patients that may r...

Eligibility Criteria

Inclusion

  • Age 8-18
  • Patient at TSRH
  • Diagnosis of lumbosacral spina bifida (myelomeningocele, meningocele, lipoma of spinal cord, myelocystocele, diastematomyelia, fatty/thickened filum)
  • Incontinence refractory to compliant catheterization (compliance with catheterization as assessed by their treating provider)
  • Patient able and willing to undergo urodynamic testing without sedation
  • No surgical reconstruction with the exception of a single appendicovesicostomy (APV)
  • No Botox treatments within 1 year of enrollment
  • Patient willing and able to stop bladder medications (anticholinergics or beta agonists) 2 weeks prior to pre-intervention bladder diary, questionnaires and UDS
  • Patient lives close enough to TSRH and CMC to be willing to return for UDS, teaching, and clinic visits as detailed above
  • Patient/family speak English

Exclusion

  • Ages \<8 or \>18
  • Diagnosis not listed above
  • Patients that have received reconstructive surgeries (i.e. augmentation or bladder neck sling) with the exception for a single APV
  • Patient received Botox treatment within 1 year of enrollment
  • Patient unable or unwilling to stop bladder medications (anticholinergics or beta agonists)
  • Patients with high-risk bladders, as assessed by their treating provider (i.e. poorly compliant bladders with high end-fill pressures)
  • Non-English speaking
  • Patients who are pregnant
  • Patients who are suspected of being pregnant
  • Patients who are nursing

Key Trial Info

Start Date :

November 18 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT06025734

Start Date

November 18 2025

End Date

May 1 2026

Last Update

December 31 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Scottish Rite for Children

Dallas, Texas, United States, 75219